23andMe Is Back On The Market -- Finally

23andMe said last month that it will once again provide direct-to-consumer genetic tests, nearly two years after the U.S. Food and Drug Administration ordered its original product off the market. Many are celebrating the return as a triumph — and an illustration of how innovation, coupled with capable leadership, can overcome regulatory hurdles.

Hey, check out all the engineering jobs. Post your resume today!

MORE ON THIS TOPIC